Feedback PLC Feedback Medical to offer Bleepa for COVID-19 (7614H)
26 März 2020 - 4:52PM
UK Regulatory
TIDMFDBK
RNS Number : 7614H
Feedback PLC
26 March 2020
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulation (EU) No. 596/2014 ("MAR").
Feedback plc
Feedback Medical to offer Bleepa to assist Coronavirus
response
-- Feedback Medical and Pennine pilot study paused to evaluate a
wider rollout to support the local COVID-19 response at the Pennine
NHS Trust
-- Bleepa(R) enables medical staff to review imaging studies and
discuss cases remotely while they or colleagues self-isolate during
the Coronavirus outbreak
-- Bleepa (R) selected for the Top 100 UK Digital Health Firms
by Healthcare UK at the Department for International Trade (DIT),
and has been included in a catalogue 100 offerings being championed
to the NHS by South East Health Technologies Alliance (SEHTA)
London, 26 March 2020: Feedback Medical Ltd, a wholly-owned
subsidiary of Feedback plc (AIM: FDBK, "Feedback" or the
"Company"), the specialist medical imaging technology company,
today announces that it will provide Bleepa (R) , Feedback's
flagship imaging-based communication platform as a tool to assist
coronavirus response.
Owing to the immense workforce pressures facing the clinical
frontline at this time, Feedback and Pennine NHS Trust have elected
to pause the Bleepa pilot, which was focusing on evaluating
specific clinical workflow applications of Bleepa, and are now
evaluating options for a wider rollout to support the local
COVID-19 response at the Trust. It is hoped that this solution will
subsequently be rolled out to other centres.
Tom Oakley, CEO of Feedback plc, said:
"The Coronavirus outbreak has created a unique and highly
pressured situation for the NHS and other healthcare providers. At
this time it is vital that clinicians who may be forced to
self-isolate are provided with a tool that will allow them to
continue supporting care delivery to colleagues who remain on the
frontline. Imaging is such a core component of delivering effective
care that any remote working solution will need to deliver access
to quality images and there is no better tool to do this than
Bleepa (R) ."
The current Coronavirus outbreak has led to a significant
increase in the volume of critical medical imaging studies, with
chest X-rays and CT scans being key aids to diagnose and manage
patients with Coronavirus. In addition to Radiologists, other
frontline clinicians will take a central role in reviewing the
growing Coronavirus caseload. As the outbreak develops these
individuals will increasingly need to review cases from home and
emergency and routine workflows will have to adapt as NHS staff
themselves increasingly become home-based as self-isolation
grows.
Home-based image review and case discussion at this scale
requires a new infrastructure and a secure bespoke imaging solution
which is capable of scaling to meet these demands. Bleepa (R) is
designed for exactly this purpose and overcomes the problems
associated with trying to scale traditional VPN-based remote access
solutions to hospital software.
Bleepa (R) is a secure image-based communication platform which
provides access to clinical grade medical images and facilitates
instant messaging based case discussion through a zero footprint
application. Bleepa (R) can be accessed from any internet connected
device including phones, tablets, laptops and desktops; clinicians
can use their own devices and therefore no additional hardware is
required.
Any medical imaging investigation can be seamlessly shared
through Bleepa (R) to the entire clinical team, even if those teams
are geographically separated or having to work remotely. Cases can
be discussed through secure instant messaging and image annotation,
allowing comments and decisions to be communicated instantly
between team members. Importantly, during the outbreak, Bleepa (R)
can enable case review by clinicians at other hospitals where
multisite communication is needed.
Bleepa is able to support care delivery in other healthcare
systems internationally and in recognition of this Bleepa has been
selected as one of the Top 100 UK Digital Health Firms by
Healthcare UK at the Department for International Trade as part of
their international offering of UK companies that could support
with coronavirus response overseas. Bleepa has also been included
in a brochure of 100 company offers compiled by the South East
Health Technologies Alliance which is being shared with NHS Trusts
as solutions that can help in the COVID-19 response. It is hoped
that these offerings will help to highlight the ability of Bleepa
to support healthcare providers both within the NHS and
internationally. Insofar as it is possible, Feedback intends to
offer Bleepa for free for the duration of the coronavirus
outbreak.
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited (Joint
Broker)
Patrick Claridge / John Howes +44 20 3815 8880
Instinctif Partners +44 (0)20 7457 2020
Melanie Toyne-Sewell / Phillip Marriage feedbackplc@instinctif.com
Notes to editors
About Feedback plc - www.fbk.com
Feedback plc (AIM: FDBK) is a specialist medical imaging
technology company providing innovative software and systems,
through its fully-owne trading subsidiary, Feedback Medical
Limited. Its products advance the work of radiologists, clinicians
and medical researchers by improving workflows and giving unique
insights into diseases, particularly cancer.
Feedback has launched Bleepa , a new secure, encrypted medical
communication app for clinicians accessible through smartphones,
tablets and desktops that facilitates rapid clinical messaging and
review of medical grade imaging for all members of a clinical team,
directly from a hospital Picture Archiving and Communications
System (PACS). For more information on Bleepa , see www.bleepa.com
.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCDZGZFKVLGGZM
(END) Dow Jones Newswires
March 26, 2020 11:52 ET (15:52 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024